Combining the differentiating effect of panobinostat with the apoptotic effect of arsenic trioxide leads to significant survival benefit in a model of t(8;21) acute myeloid leukemia

Overview of attention for article published in Clinical Epigenetics, January 2015

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 7 X posts from 7 X users, with an upper bound of 108,244 followers.

This just out in Clinical #Epigenetics : http://t.co/x923tBM3sx. Yay team!

Top #tweeted story in #bioscience: Clinical Epigenetics | Full text | Combining… http://t.co/kxaFM05R7r, see more http://t.co/iPpO7tpvoj

New in Clinical #Epigenetics: Panobinostat + arsenic trioxide to be considered for acute myeloid #leukemia http://t.co/ORx1DadZ0T

New in Clinical #Epigenetics: Panobinostat + arsenic trioxide to be considered for acute myeloid #leukemia http://t.co/ORx1DadZ0T

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 3 additional X posts.